feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Patel Engineering wins ₹798 crore order

trending

Whirlpool shares crash on reports

trending

Mars rover detects electrical sparks

trending

Comet ATLAS explodes into pieces

trending

Sensex, Nifty near record highs

trending

CTET 2026 Registration Begins

trending

RRB NTPC registration closes today

trending

Cyclone Ditwah intensifies over Bengal

trending

Shein faces EU scrutiny

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Technology / Brain Implant Turns Thoughts Into Voice

Brain Implant Turns Thoughts Into Voice

27 Nov

•

Summary

  • A new brain implant can convert neural signals into speech or text.
  • The device, Connexus BCI, uses over 400 tiny electrodes to capture brain activity.
  • The FDA approved a clinical trial to test the speech restoration technology.
Brain Implant Turns Thoughts Into Voice

Paradromics, a neurotechnology startup, is advancing brain-computer interfaces with its Connexus BCI, a fully implantable device designed to restore speech. The U.S. Food and Drug Administration (FDA) has greenlit its first human trial, marking a significant step towards clinical application for individuals with paralysis.

The Connexus BCI system features over 400 platinum-iridium electrodes, each thinner than a human hair, implanted to capture intricate neural firing patterns associated with speech. These signals are wirelessly transmitted to a computer that deciphers them into text or a synthetic voice, offering a new communication channel for those unable to speak.

This pioneering trial will initially involve two participants, evaluating the device's safety and its capability to translate neural activity into audible speech and even cursor control. If successful, the study may expand, potentially transforming assistive communication and restoring independence for many.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The Connexus BCI is a fully implantable brain device designed to capture neural signals for speech restoration and computer control.
Yes, the FDA has approved the Investigational Device Exemption for the Connect-One Early Feasibility Study using the Connexus BCI.
It records neural firing patterns in the motor cortex related to speech and uses advanced language models to convert them into text or synthesized voice.

Read more news on

Technologyside-arrow

You may also like

Zydus Lifesciences Secures FDA Tentative Approval for Diabetes Drug

8 hours ago • 2 reads

article image

Alzheimer's Gene Linked to Delirium: A Dual Brain Threat

25 Nov • 12 reads

article image

Natural Amino Acid May Cut Alzheimer's Risk, Study Finds

23 Nov • 14 reads

article image

Your Diet Could Be Fueling Brain Fog

22 Nov • 39 reads

article image

mRNA Vaccine Trial Targets Epstein-Barr Virus to Treat Multiple Sclerosis

18 Nov • 32 reads

article image